Collegium Pharmaceutical Inc (COLL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Collegium Pharmaceutical Inc (COLL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7281
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended-release drug delivery, while protecting against common methods of abuse and tampering. Its lead product, Xtampza ER is designed to provide adequate pain control. Collegium’s other products include Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy; and Nucynta for the management of acute pain severe enough to require an opioid analgesic. Collegium is headquartered in Canton, Massachusetts, the US.

Collegium Pharmaceutical Inc (COLL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Collegium Pharmaceutical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Collegium Pharma Raises USD50 Million in Venture Financing 10
Collegium Pharma Raises US$4 Million In Venture Financing 12
Equity Offering 13
Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 13
Collegium Pharma Raises USD55 Million in Public Offering of Shares 15
Collegium Pharma Raises USD80 Million in IPO 17
Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 19
Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 20
Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 21
Collegium Pharmaceutical Inc – Key Competitors 22
Collegium Pharmaceutical Inc – Key Employees 23
Collegium Pharmaceutical Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: Collegium reports second quarter financial results and provides corporate update 25
May 09, 2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018 27
Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017 29
Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update 31
Aug 09, 2017: Collegium Reports Second Quarter Financial Results and Provides Corporate Update 33
May 10, 2017: Collegium Reports 2017 First Quarter Financial Results and Provides Corporate Update 35
Mar 09, 2017: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 36
Corporate Communications 37
Jul 10, 2018: Collegium Promotes Scott Dreyer To CCO 37
Jun 04, 2018: Collegium Promotes Joseph Ciaffoni To Chief Executive Officer 38
Mar 19, 2018: Collegium Appoints Shirley Kuhlmann As General Counsel 39
May 30, 2017: Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer 40
Apr 04, 2017: Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Collegium Pharmaceutical Inc, Medical Equipment, Key Facts, 2017 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Deals By Market, 2012 to YTD 2018 8
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Collegium Pharma Raises USD50 Million in Venture Financing 10
Collegium Pharma Raises US$4 Million In Venture Financing 12
Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 13
Collegium Pharma Raises USD55 Million in Public Offering of Shares 15
Collegium Pharma Raises USD80 Million in IPO 17
Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 19
Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 20
Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 21
Collegium Pharmaceutical Inc, Key Competitors 22
Collegium Pharmaceutical Inc, Key Employees 23
Collegium Pharmaceutical Inc, Subsidiaries 24

List of Figures
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Collegium Pharmaceutical Inc (COLL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MiTek Industries, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MiTek Industries, Inc. Mergers …
  • Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • Aristocrat Leisure Ltd.の企業概要及び財務/SWOT分析
    Aristocrat Leisure Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarter …
  • Panasonic Electric Works Co., Ltd. (formerly Matsushita Electric Works, Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Panasonic Electric Works Co., L …
  • Brown-Forman Corporation:戦略・SWOT・企業財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Debiotech SA:企業のM&A・提携動向(医療機器分野)
    Summary Debiotech SA (Debiotech) is a medical device company that develops therapeutic devices and diagnostic products. The company’s products include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It develops products in the areas of implantable and exter …
  • Kier Group plc:企業のM&A・提携・投資分析
    Kier Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kier Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Vestas Wind Systems AS (VWS):企業のM&A・提携動向(エネルギー分野)
    Summary Vestas Wind Systems A/S (Vestas) is an energy equipment company that develops, manufactures, sells and maintains wind power systems. The company’s product range includes land and offshore wind turbines. It provides solutions for wind project planning; engineering, procurement, construction, …
  • H. Lundbeck A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' H. Lundbeck A/S Mergers and Acq …
  • Net Entertainment NE AB (NET B):企業概要、財務及び戦略的SWOT分析
    Summary Net Entertainment NE AB (Net Entertainment) is a software company. The company develops and markets gaming systems. It provides products such as NetEnt CasinoModule, NetEnt Live Casino and NetEnt Touch. Net Entertainment offers games, disaster recovery, account management and back office ser …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Cre8tek Limited (MAE):企業財務及び戦略的SWOT分析
    Summary Cre8tek Limited (Cre8tek), formerly known as Marion Energy Limited is an oil and gas production company. The company produces, develops, and sells oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek holds additional positions in Helper Field and in th …
  • LPL Financial Holdings Inc.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "LPL Financial Holdings Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …
  • Bill & Melinda Gates Foundation(製薬・医療分野):企業M&A動向
    Summary Bill & Melinda Gates Foundation (BMGF) is a healthcare service provider. The company concentrates on improving healthcare, decrease poverty in America, widens learning opportunities and provides access to information equipment. It provides global health services such as discovery and transla …
  • PhotoMedex, Inc. (PHMD):企業の財務及び戦略的SWOT分析
    Summary PhotoMedex, Inc. (PhotoMedex) is a medical device company that develops, manufactures and markets laser systems and products for the treatment of dermatological conditions. The company offers products such as versatile surgical laser systems, copper peptide complex technology products, solut …
  • Connect Group PLC (CNCT):企業の財務・戦略的SWOT分析
    Connect Group PLC (CNCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Biological E. Limited(製薬・医療分野):企業M&A動向
    Summary Biological E. Limited (BEL) is a pharmaceutical company. The company produces vaccines, sera and pharmaceutical products. Its business divisions include vaccines, sera, and biologics, pharma and public market. BEL’s pharmaceutical division manufactures products in the form of solid dosage fo …
  • BSP Incorporated (3800):企業概要、財務及び戦略的SWOT分析
    Summary BSP Incorporated (BSP) is an information technology service provider. The company offers software and solutions for IT systems operation. Its products include LMIS, A-AUTO, Sky-Eye Tribune, TIA Report, Exentry, Be.Learning and A-LOG, among others. BSP’s Sky-Eye Tribune is a monitoring system …
  • Statoil Fuel & Retail ASAの企業概要及び財務/SWOT分析
    Statoil Fuel & Retail ASA Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Statoil Fuel & Retail ASA annual and quarterly forecasts made by stock market experts. The report al …
  • Shin Shin Natural Gas Co., Ltd. (9918):企業財務及び戦略的SWOT分析
    Summary Shin Shin Natural Gas Co., Ltd. (Shin Shin) is an oil and gas company that supplies natural gas through pipelines. The company offers products such as gas safety and disaster prevention series, gas appliance series and series appliance. Its gas safety and disaster prevention series products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆